Abstract
No public abstract is available from the verified source records.
Yousef Hakimi, Prarthana Thiagarajan, Michael Braude
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Fatty Liver Disease in Australia: A Narrative Review on the Epidemiology, Natural History, Prognostication and Management in People With Metabolic Dysfunction
10.5694/mja2.70195 · 2026
Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
10.1053/j.gastro.2026.01.047 · 2026
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
10.2337/dci24-0094 · 2025
Placebo Rates in Metabolic Dysfunction–Associated Steatohepatitis Clinical Trials: A Systematic Review and Meta‐Analysis
10.1016/j.cgh.2025.09.035 · 2026
Continuous Glucose Monitoring as a Behavior Modification Tool
10.2337/cd19-0037 · 2020
No additional external references are available.
openalex
Confidence 95%
datacite
Confidence 0%